The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of pancreatic enzyme replacement therapy (PERT) on clinical outcomes in nonresected pancreatic cancer (PC): Initial results.
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen; Johnson & Johnson
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Abbvie; Bristol-Myers Squibb; FibroGen; Ipsen; Merck; NGM Biopharmaceuticals; Novocure; Tyme
 
Raneem Hawari
No Relationships to Disclose
 
Anas Najjar
No Relationships to Disclose
 
Diala E Harb
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jens J Kort
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Margaret T. Mandelson
Research Funding - Abbvie (Inst)